Suppressed bone turnover in obesity: a link to energy metabolism? A case-control study.
暂无分享,去创建一个
O. Mäkitie | K. Pietiläinen | S. Andersson | H. Viljakainen | K. Ivaska | M. Lipsanen-Nyman | K. Laitinen | T. Saukkonen | P. Paldánius | M. Lipsanen‐Nyman
[1] R. Lindsay,et al. Determinants of stress fracture risk in United States Military Academy cadets. , 2013, Bone.
[2] S. Cummings,et al. Effects of antiresorptive therapies on glucose metabolism: Results from the FIT, HORIZON‐PFT, and FREEDOM trials , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[3] O. Mäkitie,et al. Total and Carboxylated Osteocalcin Associate with Insulin Levels in Young Adults Born with Normal or Very Low Birth Weight , 2013, PloS one.
[4] C. Koebnick,et al. Childhood Obesity Is Associated With Increased Risk of Most Lower Extremity Fractures , 2013, Clinical orthopaedics and related research.
[5] Binsheng Zhao,et al. Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: a transiliac bone biopsy study. , 2013, The Journal of clinical endocrinology and metabolism.
[6] R. Baron,et al. What are the effects of leptin on bone and where are they exerted? , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[7] J. Martínez,et al. Young overweight and obese women with lower circulating osteocalcin concentrations exhibit higher insulin resistance and concentrations of C-reactive protein. , 2013, Nutrition research.
[8] S. Booth,et al. The role of osteocalcin in human glucose metabolism: marker or mediator? , 2013, Nature Reviews Endocrinology.
[9] Z. Şıklar,et al. Relationships Between Osteocalcin, Glucose Metabolism, and Adiponectin in Obese Children: Is there Crosstalk Between Bone Tissue and Glucose Metabolism? , 2012, Journal of clinical research in pediatric endocrinology.
[10] F. Gallé,et al. Prevalence of overweight in children with bone fractures: a case control study , 2012, BMC Pediatrics.
[11] T. Törmäkangas,et al. Serum osteocalcin is not associated with glucose but is inversely associated with leptin across generations of nondiabetic women. , 2012, The Journal of clinical endocrinology and metabolism.
[12] M. Brandi,et al. Bone mass regulation of leptin and postmenopausal osteoporosis with obesity. , 2012, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases.
[13] J. Lian,et al. Vitamin K-dependent carboxylation of osteocalcin: friend or foe? , 2012, Advances in nutrition.
[14] R. Considine,et al. Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity. , 2012, The Journal of clinical endocrinology and metabolism.
[15] M. McKee,et al. Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. , 2012, Bone.
[16] R. Eastell,et al. Obesity is a risk factor for fracture in children but is protective against fracture in adults: a paradox. , 2012, Bone.
[17] L. Hofbauer,et al. Bone, sweet bone—osteoporotic fractures in diabetes mellitus , 2012, Nature Reviews Endocrinology.
[18] O. Mäkitie,et al. The Effect of Oral Glucose Tolerance Test on Serum Osteocalcin and Bone Turnover Markers in Young Adults , 2011, Calcified Tissue International.
[19] M. Gagner,et al. Increased PTH and 1.25(OH)2D Levels Associated With Increased Markers of Bone Turnover Following Bariatric Surgery , 2011, Obesity.
[20] Y. Hwang,et al. Circulating osteocalcin level is associated with improved glucose tolerance, insulin secretion and sensitivity independent of the plasma adiponectin level , 2011, Osteoporosis International.
[21] T. Clemens,et al. The osteoblast: An insulin target cell controlling glucose homeostasis , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[22] N. Bishop,et al. Adipokines, bone-derived factors and bone turnover in obese children; evidence for altered fat-bone signalling resulting in reduced bone mass. , 2011, Bone.
[23] P. Ducy,et al. Co-dependence of bone and energy metabolisms. , 2010, Archives of biochemistry and biophysics.
[24] K. Hind,et al. In vivo precision of the GE Lunar iDXA densitometer for the measurement of total-body, lumbar spine, and femoral bone mineral density in adults. , 2010, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.
[25] R. DePinho,et al. Insulin Signaling in Osteoblasts Integrates Bone Remodeling and Energy Metabolism , 2010, Cell.
[26] Chao Wan,et al. Insulin Receptor Signaling in Osteoblasts Regulates Postnatal Bone Acquisition and Body Composition , 2010, Cell.
[27] P. Gerdhem,et al. Bone turnover markers and prediction of fracture: A prospective follow‐up study of 1040 elderly women for a mean of 9 years , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[28] J. Holst,et al. Four-month treatment with GLP-2 significantly increases hip BMD: a randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMD. , 2009, Bone.
[29] S. Booth,et al. Gamma-carboxylation of osteocalcin and insulin resistance in older men and women. , 2009, The American journal of clinical nutrition.
[30] T. Martin,et al. Bone as an endocrine organ , 2009, Trends in Endocrinology & Metabolism.
[31] D. Mellström,et al. Plasma Osteocalcin Is Inversely Related to Fat Mass and Plasma Glucose in Elderly Swedish Men , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[32] B. Dawson-Hughes,et al. Association between serum osteocalcin and markers of metabolic phenotype. , 2009, The Journal of clinical endocrinology and metabolism.
[33] R. Bouillon,et al. Bone and Metabolism: A Complex Crosstalk , 2009, Hormone Research in Paediatrics.
[34] K. Kaestner,et al. The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivity , 2008, The Journal of cell biology.
[35] G. Karsenty,et al. Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice , 2008, Proceedings of the National Academy of Sciences.
[36] J. Rissanen,et al. Secreted Tartrate-Resistant Acid Phosphatase 5b is a Marker of Osteoclast Number in Human Osteoclast Cultures and the Rat Ovariectomy Model , 2008, Calcified Tissue International.
[37] Walter C Willett,et al. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. , 2007, American journal of epidemiology.
[38] M. McKee,et al. Endocrine Regulation of Energy Metabolism by the Skeleton , 2007, Cell.
[39] P. Gerdhem,et al. Prediction of bone loss using biochemical markers of bone turnover , 2007, Osteoporosis International.
[40] J. Holst,et al. Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal women. , 2007, Bone.
[41] Mary L Bouxsein,et al. Mechanisms of Disease: is osteoporosis the obesity of bone? , 2006, Nature Clinical Practice Rheumatology.
[42] D. Balzi,et al. Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. , 2005, American journal of physiology. Endocrinology and metabolism.
[43] R. Eastell,et al. Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption , 1993, Osteoporosis International.
[44] M. Econs,et al. Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis). , 2004, Clinical chemistry.
[45] V. Bini,et al. Relationships of Serum Leptin Levels with Biochemical Markers of Bone Turnover and with Growth Factors in Normal Weight and Overweight Children , 2004, Hormone Research in Paediatrics.
[46] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[47] J. Holst,et al. Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2. , 2004, Bone.
[48] Quyen Q. Hoang,et al. Bone recognition mechanism of porcine osteocalcin from crystal structure , 2003, Nature.
[49] R. Eastell,et al. Octreotide abolishes the acute decrease in bone turnover in response to oral glucose. , 2003, The Journal of clinical endocrinology and metabolism.
[50] W. Tamborlane,et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. , 2002, The New England journal of medicine.
[51] R. Walker,et al. Diagnosing insulin resistance in the general population. , 2001, Diabetes care.
[52] M. Karp,et al. Development and evaluation of three immunofluorometric assays that measure different forms of osteocalcin in serum. , 2000, Clinical chemistry.
[53] C. Mølgaard,et al. Whole body bone mineral accretion in healthy children and adolescents , 1999, Archives of disease in childhood.
[54] Sheila M. Williams,et al. Bone Mineral Density in Girls with Forearm Fractures , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.